Picarda et al., 2019 - Google Patents
Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defensesPicarda et al., 2019
View PDF- Document ID
- 5389183464638948690
- Author
- Picarda G
- Ghosh R
- McDonald B
- Verma S
- Thiault N
- El Morabiti R
- Griffith T
- Benedict C
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Cytomegalovirus (CMV) establishes a lifelong infection facilitated, in part, by circumventing immune defenses mediated by tumor necrosis factor (TNF)-family cytokines. An example of this is the mouse CMV (MCMV) m166 protein, which restricts expression of the TNF-related …
- 102000007193 TNF-Related Apoptosis-Inducing Ligand 0 title abstract description 120
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Role of PDGF receptor-α during human cytomegalovirus entry into fibroblasts | |
| Kato | New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors | |
| Park et al. | Toxoplasma gondii infection drives conversion of NK cells into ILC1-like cells | |
| Chijioke et al. | Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection | |
| Ganem | KSHV infection and the pathogenesis of Kaposi's sarcoma | |
| Willis et al. | Transcription factor IRF4 regulates germinal center cell formation through a B cell–intrinsic mechanism | |
| Choi et al. | Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses | |
| Park et al. | Cytokine‐induced megakaryocytic differentiation is regulated by genome‐wide loss of a uSTAT transcriptional program | |
| Ok et al. | EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management | |
| Andreone et al. | Posttransplantation lymphoproliferative disorders | |
| Liu et al. | Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia | |
| Bangham et al. | Human T-cell leukaemia virus type 1: parasitism and pathogenesis | |
| Marro et al. | Discovery of small molecules for the reversal of T cell exhaustion | |
| Picarda et al. | Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defenses | |
| Avdic et al. | Human cytomegalovirus-encoded human interleukin-10 (IL-10) homolog amplifies its immunomodulatory potential by upregulating human IL-10 in monocytes | |
| Yamin et al. | The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors | |
| Elboim et al. | HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing | |
| Wilson et al. | Gamma interferon controls mouse polyomavirus infection in vivo | |
| Butler et al. | Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion | |
| Tsai et al. | Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation | |
| Schepis et al. | Herpes simplex virus infection downmodulates NKG2D ligand expression | |
| Ma et al. | BAFF suppresses IL-15 expression in B cells | |
| Thackray et al. | Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection | |
| Iancovici et al. | Rheumatoid arthritis patients treated with Janus kinase inhibitors show reduced humoral immune responses following BNT162b2 vaccination | |
| Stack et al. | CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue |